1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
(
- Contribution to journal › Article
-
Mark
Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital.
(
- Contribution to journal › Article
- 2006
-
Mark
Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients
2006) 36th Annual Metting of the Environmental Mutagen Scociety(
- Contribution to conference › Abstract
- 2005
-
Mark
Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in sweden.
(
- Contribution to journal › Article
-
Mark
Metod för provtagning av cytostatikakontaminerade ytor samt tillämpning i beredningscentral för cytostatika. Nordiska Arbetsmiljömötet
2005) Nordiska Arbetsmiljömötet, 2005(
- Contribution to conference › Abstract
-
Mark
Kontamination av cytostatika på golvytor på onkologisk dagvårdsavdelning
2005) Svenska Läkaresällskapets Riksstämma, 2005(
- Contribution to conference › Abstract
- 2004
-
Mark
Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces.
(
- Contribution to journal › Article
-
Mark
ANALYTICAL METHODS FOR BIOLOGICAL MONITORING OF CYCLOPHOSPHAMIDE IN URINE AND IN PLASMA
2004) Sixth International Symposium on Biological Monitoring in Occupational & Environmental Health(
- Contribution to conference › Abstract
- 2003
-
Mark
Cyklofosfamid (CP) i urin vid riskvärdering vid cytostatikaarbete
2003) Svenska Läkaresällskapets Riksstämma, 2003(
- Contribution to conference › Abstract